Nanjing Puguang Biotechnology Co., Ltd announced that it has received $15 million in funding from Huatai Zijin Investment Co. Ltd, Nanjing XinGong Investment Group Co., Ltd, Shanghai Wenzhou Investment Management Co., Ltd., Jointown Pharmaceutical Group Co., Ltd
July 10, 2022
Share
Nanjing Puguang Biotechnology Co., Ltd announced that it has received $15 million in a round of funding co-led by Huatai Zijin Investment Co. Ltd and Nanjing XinGong Investment Group Co., Ltd. on July 11, 2022. The transaction also includes participation from Shanghai Wenzhou Investment Management Co., Ltd., Jointown Pharmaceutical Group Co., Ltd.
Jointown Pharmaceutical Group Co., Ltd. is principally engaged in the wholesaling and retailing of pharmaceuticals and medical equipments. The Company is also engaged in the research, development and production of drugs, as well as the provision of relevant value-added services. The Companyâs products mainly include western medicines, proprietary Chinese medicines, Chinese medicine pieces, Chinese herbal medicines, medical equipments, health care products, cosmetics, among others. The Company mainly provides services to direct sales or franchise stores through its retailing businesses.
Nanjing Puguang Biotechnology Co., Ltd announced that it has received $15 million in funding from Huatai Zijin Investment Co. Ltd, Nanjing XinGong Investment Group Co., Ltd, Shanghai Wenzhou Investment Management Co., Ltd., Jointown Pharmaceutical Group Co., Ltd
JOINTOWN PHARMACEUTICAL GROUP CO., LTD 
